Found vs Henry Meds vs Lavender Sky Health (2026)

On tirzepatide, the order is Found ($289) → Henry Meds↗ ($349) → Lavender Sky Health↗ ($352) — gaps of $60 and then $3 a month, a $756 spread across a year between first and last. All-in figures, 10 mg basis, captured 2026-08-09.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

§ Each record, condensed

The three records, one screen

Found: the record, condensed

On tirzepatide, the number that matters at Found is $289 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. It is a flat structure: 2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.

To place the number: #6 of 17 verified programs, with the floor $74/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $160 a month. A year at this figure: $3,468 monthly-billed.

On semaglutide, the number that matters at Found is $289 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $289 is the whole subscription, which makes Found unusually easy to compare and unusually easy to leave.

Context for that figure: it ranks #15 of 20 in the verified semaglutide index — $156/month above the floor (Oak Longevity, $133) — and sits $60 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $3,468.

Operationally at Found: shipping included; commitment none month-to-month; prepaid terms for lowest rate; cancellation membership recurs; prepaid terms are paid up front; pharmacy not publicly named — ask in writing before paying; states: most states; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Found page · visit Found ↗

Henry Meds: the record, condensed

Start with the load-bearing figure: $349 a month, all-in, is what Henry Meds charges for tirzepatide at the 10 mg basis. It is a flat structure: 2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

There is no membership line. $349 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

To place the number: #10 of 17 verified programs, with the floor $134/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $100 a month. A year at this figure: $4,188 monthly-billed.

On semaglutide, the number that matters at Henry Meds is $179 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at Henry Meds is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

There is no membership line. $179 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

Context for that figure: it ranks #9 of 20 in the verified semaglutide index — $46/month above the floor (Oak Longevity, $133) — and sits $170 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $2,148.

Operationally at Henry Meds: shipping included; commitment none month-to-month; cancellation check terms before prepaying; pharmacy not publicly named — ask in writing before paying; states: most states; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Henry Meds page · visit Henry Meds ↗

Lavender Sky Health: the record, condensed

Start with the load-bearing figure: $352 a month, all-in, is what Lavender Sky Health charges for tirzepatide at the 10 mg basis. Pricing steps with the dose here: from $200 at entry to $352 at the 10 mg basis. Multiply the wrong one of those by twelve and your budget is off by $1,824 a year, which is why every ranking on this site uses the larger number.

A required $25/month membership is part of the deal, and part of the figure above: $327 of medication plus $25 of platform equals the $352 that leaves your account. Judge the membership by what it includes, but compare on the total.

To place the number: #12 of 17 verified programs, with the floor $137/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $97 a month. A year at this figure: $4,224 monthly-billed.

Start with the load-bearing figure: $174 a month, all-in, is what Lavender Sky Health charges for semaglutide at the 2.4 mg basis. The figure is quoted at maintenance without a separate teaser tier, which keeps the arithmetic honest by default.

A required $25/month membership is part of the deal, and part of the figure above: $149 of medication plus $25 of platform equals the $174 that leaves your account. Judge the membership by what it includes, but compare on the total.

Context for that figure: it ranks #6 of 20 in the verified semaglutide index — $41/month above the floor (Oak Longevity, $133) — and sits $175 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $2,088.

Operationally at Lavender Sky Health: shipping included; commitment monthly plan fee recurs; cancellation plan fee recurs until cancelled; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Lavender Sky Health page · visit Lavender Sky Health ↗

§ The three-way read

Prices, gaps, and what sits inside them

Found holds the low ground at $289 — dose-flat, so that figure is a ceiling with no membership attached. Henry Meds follows at $349 (+$60/mo, $720/yr). Lavender Sky Health tops the trio at $352 (+$63/mo over the leader, $756/yr) — note its record’s watch-out below.

The semaglutide picture reshuffles the order: Lavender Sky Health $174 → Henry Meds $179 → Found $289 — a reminder that molecule choice and provider choice are separate decisions, priced separately in the semaglutide index.

§ Category winners among the three

Who wins what

Cheapest month-to-month: Found ($289); cheapest 12-month path: Found ($3,468); simplest billing (no membership): Found and Henry Meds; dose-flat structure: Found and Henry Meds; cheapest semaglutide of the three: Lavender Sky Health ($174).

Every winner above is a computation, not a placement; the pairwise pages carry the full duels: Found vs Henry Meds · Found vs Lavender Sky Health (record · record) · Henry Meds vs Lavender Sky Health (record · record).

§ Structure, three ways

Everything besides the three prices

Memberships: Found none; Henry Meds none; Lavender Sky Health $25/mo (inside its figure). Structures: Found dose-flat; Henry Meds dose-flat; Lavender Sky Health step/tiered. Pharmacies: Found not named; Henry Meds not named; Lavender Sky Health not named. States: Found — most states; Henry Meds — most states; Lavender Sky Health — not published. Exit terms: Found — membership recurs; prepaid terms are paid up front; Henry Meds — check terms before prepaying; Lavender Sky Health — plan fee recurs until cancelled.

The census reading: where all three match on an axis, that axis cannot break the tie and the price column rules; where they split — a membership here, an unnamed pharmacy there — the split is usually worth more than a small price gap, because structure is what you live with after month one. Evidence for all three: Found third-party reported (2026-08-05); Henry Meds third-party reported (2026-08-05); Lavender Sky Health source-verified (2026-08-05).

The trio on semaglutide, across time

3 mo: Lavender Sky Health $522 vs Henry Meds $537 vs Found $867 6 mo: Lavender Sky Health $1,044 vs Henry Meds $1,074 vs Found $1,734 12 mo: Lavender Sky Health $2,088 vs Henry Meds $2,148 vs Found $3,468 — monthly-billed totals; prepaid paths where published appear on each provider page.

§ Twelve and twenty-four months

The trio, annualized

Found: $3,468/yr monthly-billed; Henry Meds: $4,188/yr monthly-billed; Lavender Sky Health: $4,224/yr monthly-billed. Across two years at monthly billing the first-to-last spread widens to $1,512 — the horizon at which structure (prepaid ladders, flat pricing, membership drag) matters more than the sticker.

The elimination read

A three-way choice is really two eliminations, so run them in order. Eliminate Lavender Sky Health first unless it names its edge: at $352 it carries a $63/month premium over the floor of this trio — $756 a year, about 2.6 extra months of therapy at Found’s rate — and a premium that size must point at a specific line in its record (the services inside its $25/mo membership) or it is decoration. Then interrogate Henry Meds’s middle ground: nothing structural — its case is purely situational; if that specific thing is on your personal ledger, the $60/month over the floor can be rational — if not, the middle is where budgets go to leak. What survives is Found at $289, which wins by default rather than by argument — exactly how a price index should crown things — subject to the two checks no ranking can run for you: your state at intake, and your prescriber on the medication itself.

The same trio on best published rate: Found $289 → Henry Meds $349 → Lavender Sky Health $352 — all three price month-to-month only at capture. Short-horizon totals, monthly-billed: 3 months — Found $867, Henry Meds $1,047, Lavender Sky Health $1,056; 6 months — Found $1,734, Henry Meds $2,094, Lavender Sky Health $2,112. 0 of the three publish a prepaid path below their own monthly billing; the twelve- and twenty-four-month table below carries those, labeled.

The record-quality read, scored on the five checkable disclosures this index tracks (maintenance price, named pharmacy, published states, published cancellation terms, source-verified capture): Found 3/5, Henry Meds 3/5, Lavender Sky Health 4/5. Lavender Sky Health discloses the most and Found the least, and in this market disclosure predicts disclosure — the axis where a program goes quiet is reliably where its checkout surprises live. The three match on every disclosure axis, which is rare and worth noting in their favor collectively. Scores recompute from the public records like everything else here.

Read as a decision: start from Found and make the other two argue upward. Henry Meds’s case is its structure; Lavender Sky Health’s case must be worth $756 a year in named features — the honest unit being months of medication (2.6 of them at the floor rate). The pairwise pages above hold each argument in full, and the calculator holds your version of it.